HempNewsBreaks

WednesdayOct 06, 2021 1:57 pm

HempNewsBreaks – Red White & Bloom Brands Inc. (CSE: RWB) (OTCQX: RWBYF) Achieves 13% QOQ Revenue Growth, Marks Remarkable Q2 2021

Red White & Bloom Brands (CSE: RWB) (OTCQX: RWBYF) recently released its financial results for the second quarter of fiscal 2021. The company’s revenue was up 13% to $13.3 million, from $11.8 million in Q1 2021. In addition to a growth in revenue, RWB also received the Florida Department of Health, Office of Medical Marijuana Use approval; closed the acquisition of Acreage Florida; secured 20 double wide fully enclosed cultivation pods that will offer approximately 19,000 square feet of turn-key cultivation space; and completed the more comprehensive portion of Michigan’s two-step application process for medical marijuana licensing through its wholly…

Continue Reading

TuesdayOct 05, 2021 2:53 pm

HempNewsBreaks – Golden Triangle Ventures Inc. (GTVH) Releases Preliminary Results Showing HyGrO Technology Could Increase Longevity of Cut Flowers

Golden Triangle Ventures (OTC: GTVH) released the successful results of preliminary testing of its proprietary HyGrO hydrogen water technology and is looking forward to pursuing larger-scale studies. The company will work with commercial-scale flower products to further evaluate the efficacy of GTVH’s new process. The preliminary research, which lasted 21 days, was designed to assess whether hydrogen-infused water via the HyFrontier Technologies HyGrO system would increase the longevity of cut flowers, including stock roses, carnations and gladiolas. “Two vases were filled, one with regular tap water and one with HyGrO water. The water was never changed, and pictures were taken…

Continue Reading

WednesdaySep 29, 2021 1:35 pm

HempNewsBreaks – Lexaria Bioscience Corp.’s (NASDAQ: LEXX) DehydraTECH(TM) Provides Improved Delivery for Wide Range of Product Formats

Lexaria Bioscience Corp. (NASDAQ: LEXX), an innovator of drug delivery methods, is improving the speed and efficiency of orally delivered fat-soluble active molecules and drugs with its patented technology. “DehydraTECH promotes a more effective, less expensive form of oral drug delivery evaluated thoroughly in vivo, in vitro and human clinical testing,” reads a recent article. “The DehydraTECH technology is suitable for use with a wide range of product formats. These include pharmaceuticals, nutraceuticals, consumer packaged goods, and over-the-counter (‘OTC’) capsules, pills, tablets, and oral suspensions. The technology was specifically designed for formulating and delivering lipophilic (fat-soluble) drugs and active ingredients…

Continue Reading

MondaySep 27, 2021 1:10 pm

HempNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Eyes Commercial Plans to Become B2B Wholesale Supplier of Rare Cannabinoids

InMed Pharmaceuticals (NASDAQ: INM), a clinical-stage company based in British Columbia, Canada, is focused on advancing a pipeline of cannabinoid-based pharmaceutical drug candidates. The company is developing a proprietary cannabinoid synthesis manufacturing system known as IntegraSyn(TM), which is designed to advance rare and lesser-known cannabinoid production to commercial levels. A recent article discussing this quotes InMed CEO Eric A. Adams. “The next key milestone is to manufacture our first large-scale batch through a pharma-grade-ready process in the coming months. We will continue to optimize the process and scale up the IntegraSyn process into larger vessels,” Adams said in a recent…

Continue Reading

MondaySep 27, 2021 12:54 pm

HempNewsBreaks – Flora Growth Corp. (NASDAQ: FLGC) Completes First Step in European Expansion Plan

Flora Growth Corp. (NASDAQ: FLGC) recently closed a €2 million investment in Hoshi International Inc., a fully integrated cannabis company, and uniquely positioned to become the leading provider of cannabis and derivative products for the budding European market. With the investment, Flora is set to capitalize on Hoshi’s strong European presence as well as leverage its technical know-how and understanding of its European market to not only expand its reach but also obtain its European Union Good Manufacturing Practices (“EU-GMP”) certification. A recent article reads, “Flora hopes to capitalize on Hoshi’s understanding of and presence within the European market to…

Continue Reading

FridaySep 24, 2021 2:14 pm

HempNewsBreaks – Lexaria Bioscience Corp.’s (NASDAQ: LEXX) DehydraTECH(TM) Enhancing Performance of Antiviral Drugs, CBD

Lexaria Bioscience Corp. (NASDAQ: LEXX) is making significant progress in advancing its patented DehydraTECH(TM) drug delivery technology. Lexaria recently reviewed its successful 2021 antiviral drug program. “The company has progressed significantly in evidencing that DehydraTECH can sufficiently enhance the usable fraction of known antiviral drugs that reach the bloodstream to safely and more effectively do what they are designed to accomplish,” reads a recent article. In addition to the antiviral program, Lexaria is also focused on another applied R&D program — hypertension. On July 29, it released partial results from a human clinical study, HYPER-H21-1, evaluating DehydraTECH-processed cannabidiol (“CBD”) for…

Continue Reading

FridaySep 24, 2021 1:57 pm

HempNewsBreaks – Red White & Bloom Brands Inc. (CSE: RWB) (OTCQX: RWBYF) Continuing Momentum to Grow Sales, Revenue

Red White & Bloom Brands (CSE: RWB) (OTCQX: RWBYF) is a pioneer in cannabis and hemp-derived product lines, strategically positioning itself to be among the top three multistate operators of these products within the American market. In late July of this year, the company released its Q1 2021 financial results in what Brand Rogers, RWB Chairman and CEO, described as “another great quarter for the company.” A recent article reads, “When making the announcement, Mr. Rogers also noted that the company would be building on the momentum from Q1, given how much traction it had received for its brand. More…

Continue Reading

WednesdaySep 22, 2021 3:46 pm

HempNewsBreaks – Golden Triangle Ventures Inc. (GTVH), Positron Partner to Tap into Lucrative Virtual Reality Events Space

Golden Triangle Ventures (OTC: GTVH) has partnered with Positron, a leading virtual reality (“VR”) technology and entertainment company, in a five-year agreement that places it in a strong position in the VR event space. Online pay-per-view performances became an option for artists to eke out a living following the pandemic-imposed restrictions. However, a recent article, which contains excerpts from a Forbes publication, notes that GTVH believes the real promise is in VR concerts, effectively agreeing with the Forbes piece. “Virtual reality concerts, although less common than online pay-per-view concerts, are potentially much more lucrative,” reads the article. Positron’s platform, developed…

Continue Reading

FridaySep 17, 2021 3:26 pm

HempNewsBreaks – Golden Triangle Ventures Inc. (GTVH) to Assist Le Pragma in Strategic Vision to Become ‘CBD Line of the Future’

Golden Triangle Ventures (OTC: GTVH) recently signed a letter of intent to acquire Le Pragma LLC, a trusted product line with a focus on quality and consistent results. “Le Pragma features a full retail offering of high-end, all-natural health, wellness and beauty products. Leveraging the resources and expertise of Sonder Fulfillment, its wholly owned subsidiary, Golden Triangle plans to help Le Pragma achieve its strategic vision of becoming the CBD line of the future,” reads a recent article. Le Pragma, which has always committed to quality and an end goal to provide luxurious cannabinoid products throughout the world, will leverage…

Continue Reading

FridaySep 17, 2021 2:57 pm

HempNewsBreaks – Lexaria Bioscience Corp.’s (NASDAQ: LEXX) DehydraTECH(TM) Enables Rapid, Sustained Drop in Blood Pressure

Lexaria Bioscience Corp. (NASDAQ: LEXX), a global innovator of proprietary patented drug-delivery platform DehydraTECH(TM), recently released partial results from human clinical study HYPER-H21-1. The study evaluated DehydraTECH-processed cannabidiol (“CBD”) for potential application against hypertension/high blood pressure. “The partial results showed that blood pressure was reduced across both male and female volunteers; it was more pronounced with DehydraTECH-CBD in the study’s first 10 to 50 minutes. These results reinforced the pre-existing findings demonstrating that DehydraTECH delivers superior performance over generic CBD controls,” reads a recent article. Lexaria was also pleased that the subjects of this human clinical study tolerated the DehydraTECH-CBD,…

Continue Reading